Screener
Upstream Bio, Inc. UPB CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Upstream Bio, Inc.’s 10-K, filed March 26, 2026.
- Filed
- Mar 26, 2026, 4:04 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-126188
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 |
|---|---|---|
| Cash flows from investing activities: | ||
| Purchases of short-term investments | (385,878) | (290,609) |
| Maturities of short-term investments | 292,563 | 231,635 |
| Purchases of equipment | (165) | (511) |
| Net cash used in investing activities | (93,480) | (59,485) |
| Cash flows from financing activities: | ||
| Proceeds from the issuance of Series B redeemable convertible preferred stock, net of issuance costs paid | — | 149,924 |
| Proceeds from initial public offering, net of underwriters discounts and commissions | — | 272,723 |
Item 16. Form 10-K Summary.
FAQ
- What is Upstream Bio, Inc.'s capex?
- Upstream Bio, Inc. (UPB) reported capex of $54K in Q4 2025.
- How has Upstream Bio, Inc.'s capex changed year-over-year?
- Upstream Bio, Inc.'s capex decreased by 70.8% year-over-year, from $185K to $54K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Upstream Bio, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude